September 9th, 2010
Posted on 04. Mar, 2010 by PublicWire in Medical
3/4 (POSC.OB) Positron Corporation Sells Attrius™ PET scanner to Ochsner Health System
(PublicWire) — Positron Corporation (OTCBB: POSC) a molecular imaging solutions company focused on Nuclear Cardiology, announced the sale of its Attrius™ PET scanner to Ochsner Health System of Louisiana.
The Attrius(TM) is the only PET scanner on the market optimized for myocardial perfusion imaging with several specialized features making it the scanner of choice for nuclear cardiologist’s who value high quality PET imaging and cardiovascular specific interpretation tools.
Robert Bober, M.D., F.A.C.C, Director of Nuclear Cardiology at Ochsner states, “We are eager to offer Louisiana residents the best technology for coronary disease detection.” Dr. Bober went on to state, “We selected Positron as our preferred vendor due to their dedication to high quality cardiology imaging and their vast amount of experience in this field.”
Joseph Oliverio, Chief Technology Officer of Positron states, “The Attrius sale to Ochsner demonstrates our expanding market beyond private cardiology practices. We are grateful to have such a prestigious hospital network join our user group.” Oliverio further stated, “Positron has the ideal solution for thousands of cardiology groups and hospitals looking to improve their diagnostic accuracy at an affordable price. As a Company we have always been at the forefront of cardiac PET and see the market for our products and industry continue to expand at a rapid rate. As evidence we are experiencing an unprecedented demand for our new device.”
About Positron:
Positron founded in 1983, is a molecular imaging company focused on Nuclear Cardiology. Positron utilizes its proprietary product line to provide unique solutions to the Nuclear Medicine community ranging from imaging systems to radiopharmaceutical distribution. Positron products include: the Attrius(TM), a PET imaging device; the Pulse(R), a SPECT imaging device; the Nuclear Pharm-Assist(R), an automated radiopharmaceutical distribution device; and the Tech-Assist(TM), a radiopharmaceutical injection shield. Positron is headquartered in Indianapolis, Indiana. More information about Positron is available at www.positron.com.
Forward Looking Statements:
Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended. These statements are based on many assumptions and estimates and are not guarantees of future performance and may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Positron Corporation to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as “Risk Factors” in our filings with the Securities and Exchange Commission.
